UnitedHealth Group Incorporated $UNH Shares Sold by Hartford Funds Management Co LLC

Hartford Funds Management Co LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 92.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 421 shares of the healthcare conglomerate’s stock after selling 5,518 shares during the quarter. UnitedHealth Group comprises 0.0% of Hartford Funds Management Co LLC’s holdings, making the stock its 27th biggest position. Hartford Funds Management Co LLC’s holdings in UnitedHealth Group were worth $131,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. ProShare Advisors LLC boosted its holdings in UnitedHealth Group by 5.1% in the second quarter. ProShare Advisors LLC now owns 279,291 shares of the healthcare conglomerate’s stock valued at $87,130,000 after purchasing an additional 13,538 shares during the last quarter. Summit X LLC raised its stake in UnitedHealth Group by 428.0% in the 2nd quarter. Summit X LLC now owns 15,042 shares of the healthcare conglomerate’s stock valued at $4,692,000 after purchasing an additional 12,193 shares during the last quarter. Roberts Glore & Co. Inc. IL purchased a new position in UnitedHealth Group in the 2nd quarter worth approximately $1,503,000. PFG Advisors grew its position in shares of UnitedHealth Group by 19.9% in the second quarter. PFG Advisors now owns 13,574 shares of the healthcare conglomerate’s stock valued at $4,235,000 after purchasing an additional 2,252 shares in the last quarter. Finally, Midwest Trust Co acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth $20,941,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Bank of America upped their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Finally, UBS Group lifted their price objective on shares of UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Trading Up 0.8%

Shares of UNH stock opened at $324.29 on Monday. The business’s 50 day moving average is $345.84 and its two-hundred day moving average is $321.90. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $293.75 billion, a P/E ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the business earned $7.15 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.